<DOC>
	<DOCNO>NCT02730663</DOCNO>
	<brief_summary>The purpose study evaluate safety effectiveness endoscopic ultrasound ( EUS ) -guided transluminal drainage 'Niti-S SPAXUS Stent ' treatment pancreatic pseudocyst .</brief_summary>
	<brief_title>A Study Evaluate Effectiveness Safety EUS-guided Transluminal Drainage With 'Niti-S SPAXUS Stent '</brief_title>
	<detailed_description>'Niti-S SPAXUS Stent ' newly design lumen-apposing fully cover self-expandable metal stent . It indicate use patient pancreatic pseudocyst . Consecutive subject data collect discharge , stent removal ( day 30 60 ) , day 20 post Niti-S SPAXUS stent removal .</detailed_description>
	<mesh_term>Pancreatic Pseudocyst</mesh_term>
	<criteria>Pancreatic pseudocyst ≥6cm size , ≥70 % fluid content eligible transluminal drainage Patient willing provide write informed consent comply followup requirement Ineligible endoscopic intervention Pancreatic pseudocyst severe internal septation Platelet count &lt; 60,000 cells/mm3 INR &gt; 1.5 Hemodynamic instability ( e.g . shock ) Active infectious disease ( e.g . endocarditis , meningitis ) Participating investigational drug device clinical trial within past 3 month Female childbearing potential unable take adequate contraceptive precaution , know pregnant , currently breastfeed infant</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Endoscopic ultrasound guide transluminal drainage</keyword>
</DOC>